Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$83.83+1.73 (+2.11%)
Close on Nov 18, 2026Market cap $6.58BP/E –Yield –
Abivax shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Abivax's shares outstanding was 80M at Jun 30, 2026. For fiscal 2025 it was 70M, up 10.3% from the year before. The highest annual figure on record is 70M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70M | +10.3% |
| FY2024 | Dec 31, 2024 | 63M | +46.4% |
| FY2023 | Dec 31, 2023 | 43M | +125.6% |
| FY2022 | Dec 31, 2022 | 19M | +23.5% |
| FY2021 | Dec 31, 2021 | 15M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 80M | +25.5% |
| Q1 FY2026 | Mar 31, 2026 | 79M | +24.6% |
| Q4 FY2025 | Dec 31, 2025 | 78M | +23.9% |
| Q3 FY2025 | Sep 30, 2025 | 73M | +15.4% |
| Q2 FY2025 | Jun 30, 2025 | 63M | +0.8% |
| Q1 FY2025 | Mar 31, 2025 | 63M | +0.7% |
| Q4 FY2024 | Dec 31, 2024 | 63M | – |
| Q3 FY2024 | Sep 30, 2024 | 63M | – |
| Q2 FY2024 | Jun 30, 2024 | 63M | – |
| Q1 FY2024 | Mar 31, 2024 | 63M | – |
See a number that looks wrong?